Deep Research is currently powered by Gemini 1.5 Pro. Google will presumably use 2.0 Pro once that exits the experimental phase, but it’s unclear when that upgrade will happen.

Interdisciplinary research teams strive for innovative approaches to cultural heritage preservation, funded by the National ...

Clean energy installations in the U.S. reached a record high last year, with the country adding 47% more capacity than in ...

Leading executives have largely avoided criticizing Trump and his plans. It’s reasonable to question, however, whether that’s ...

OpenAI announced on X that it’s hosting a livestream from Tokyo tonight, offering no more context beyond, “Deep Research.” ...

Managers often grapple with whether to be lenient or punitive when addressing employee misconduct. While leniency may seem ...

A team led by Harvard SEAS Postdoctoral Fellow Dr. John Zimmerman and including NTT Research Medical and Health Informatics Scientist Ryoma Ishii, Harvard SEAS Tarr Family Professor of Bioengineering ...

I’m a health researcher. NIH’s pause on research grants could have a devastating cost. This is a potentially devastating ...

Deep research can reportedly carry out tasks on users' behalf to create a comprehensive report by synthesizing data from online sources, just like a research analyst.

Context Therapeutics (CNTX) announced that the first patient has been dosed in its Phase 1 clinical trial evaluating CTIM-76, a Claudin 6, or CLDN6, x CD3 T cell engaging bispecific antibody. The ...

Diarrheagenic E. coli (DEC) is a major global cause of diarrheal diseases, with certain strains showing alarming levels of antibiotic resistance.

Needham raised the firm’s price target on Confluent (CFLT) to $40 from $31 and keeps a Buy rating on the shares after its Q4 earnings beat.